Kailera Therapeutics, Inc.
S-1 FiledKLRA
Kailera Therapeutics, Inc. IPO
Monitoring
S-1 Filed
Priced
Trading
Est. valuation
$100M
Exchange
—
Ticker: KLRA
Status
S-1 Filed
Filed
Mar 27, 2026
FireStrike Analysis
FireStrike is tracking the Kailera Therapeutics, Inc. IPO. Analysis and commentary will appear here as filings, roadshow details, and pricing information become available. Subscribe to the daily brief to get updates the morning they happen.
Frequently asked questions
When is Kailera Therapeutics, Inc. going public?
Kailera Therapeutics, Inc. has not yet announced an IPO date or filed a registration statement with the SEC. FireStrike will update this page when official filings or announcements are made.
What is Kailera Therapeutics, Inc.'s IPO valuation?
The estimated offering value is $100M. Final valuation will be determined at pricing.
What exchange will Kailera Therapeutics, Inc. list on?
No exchange has been officially announced for the Kailera Therapeutics, Inc. IPO.
Has Kailera Therapeutics, Inc. filed an S-1 with the SEC?
No. As of the most recent data, Kailera Therapeutics, Inc. has not filed a Form S-1 or other registration statement with the SEC.
Sources: FireStrike proprietary index · SEC EDGAR